29 April 2015

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:30 and is anticipated to finish by 16:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting

2. Apologies

3. Any other business

4. Skin cancer: the VivaScope 1500 and 3000 systems for detecting and monitoring skin lesions

4.1. Declarations of interest - Part 1 only (open session)

4.2. Introduction by the Chair, Professor Mark Kroese - Part 1 only    (open session)

4.3. Presentation by the Lead team, Professor Chris Hyde and Dr Rakesh Patalay - Part 1 and Part 2 (open and closed session)

4.4. Agreement on the content of the Diagnostic Consultation Document (DCD) - Part 2 only (closed session)

Date, time and venue of next meeting.

Tuesday 26 May 2015 10.30 – 16.00, NICE, Level 1a, City Tower, Piccadilly Plaza, Manchester, M1 4BT

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Wednesday 15 April 2015. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator, Sandra Robinson, at sandra.robinson@nice.org.uk

 

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk.

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

Registration period: 30 March 2015 to 15 April 2015
Registration is closed.